A novel drug holds promise for treating Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes severe muscle ...

On their family farm in rural Illinois, the Flessner boys have free range. But early on, something was holding older brother ...

Columnist Shalom Lim appreciates how Duchenne never offers a dull moment as he prepares for the challenges and adventures in ...

From imaging innovations to new treatment approvals, 2024 brought advancements in Duchenne muscular dystrophy care and ...

An advanced centre for treating muscular dystrophy will soon be established at Chacha Nehru Children’s Hospital. The decision ...

A preclinical study at McGill University suggests that’s an experimental compound called K884 can potentially boost the ...

A host of well-known faces are urging their followers to help fund gene therapy for a little boy who needs treatment abroad ...

Department of Health (DoH) of Hong Kong approved AGAMREE® for the treatment of Duchenne muscular dystrophy (DMD) in patients aged 4 years and older Follows recent approval from China’s National ...

McGill researchers discovered that K884, an experimental drug, enhances muscle stem cell repair in Duchenne muscular ...

Patients with Duchenne muscular dystrophy now have new hope with gene ... and now gene replacement therapy – have changed the treatment landscape. For the Flessners, it’s a double blessing.

MDA announces over $5 million in grants to advance neuromuscular disease research, including 14 research grants and 7 ...

Department of Health (DoH) of Hong Kong approved AGAMREE® for the treatment of Duchenne muscular dystrophy (DMD) in patients aged 4 years and older Follows recent approval from China’s National ...